Related references
Note: Only part of the references are listed.Regulation of synaptic vesicle acidification at the neuronal synapse
Sindhuja Gowrisankaran et al.
IUBMB LIFE (2020)
Berberine alleviates rotenone-induced cytotoxicity by antioxidation and activation of PI3K/Akt signaling pathway in SH-SY5Y cells
Han Deng et al.
NEUROREPORT (2020)
How Important Is the Use of Cocaine and Amphetamines in the Development of Parkinson Disease? A Computational Study
Domen Pregeljc et al.
NEUROTOXICITY RESEARCH (2020)
Neurodegenerative Diseases - Is Metabolic Deficiency the Root Cause?
Vignayanandam Ravindernath Muddapu et al.
FRONTIERS IN NEUROSCIENCE (2020)
Chronic Administration of Fipronil Heterogeneously Alters the Neurochemistry of Monoaminergic Systems in the Rat Brain
Rahul Bharatiya et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
L-3,4-dihydroxyphenylalanine (L-DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha-synuclein mouse models of Parkinson's disease
Jessica L. Billings et al.
JOURNAL OF NEUROCHEMISTRY (2019)
A Computational Model of Loss of Dopaminergic Cells in Parkinson's Disease Due to Glutamate-Induced Excitotoxicity
Vignayanandam Ravindemath Muddapu et al.
FRONTIERS IN NEURAL CIRCUITS (2019)
Calcium, Dopamine and Neuronal Calcium Sensor 1: Their Contribution to Parkinson's Disease
Cristina Catoni et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
Inflammation, Infectious Triggers, and Parkinson's Disease
Elisa Caggiu et al.
FRONTIERS IN NEUROLOGY (2019)
The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson's disease
B. R. Bloem et al.
BMC NEUROLOGY (2019)
Inorganic Polyphosphate Regulates AMPA and NMDA Receptors and Protects Against Glutamate Excitotoxicity via Activation of P2Y Receptors
Marta Maiolino et al.
JOURNAL OF NEUROSCIENCE (2019)
Disubstituted Dithiolethione ACDT Exerts Neuroprotective Effects Against 6-Hydroxydopamine-Induced Oxidative Stress in SH-SY5Y Cells
Swati Betharia et al.
NEUROCHEMICAL RESEARCH (2019)
Early neurochemical modifications of monoaminergic systems in the R6/1 mouse model of Huntington's disease
Emilie Puginier et al.
NEUROCHEMISTRY INTERNATIONAL (2019)
Effect of L-DOPA/Benserazide on Propagation of Pathological α-Synuclein
Aki Shimozawa et al.
FRONTIERS IN NEUROSCIENCE (2019)
Levodopa treatment in Parkinson's disease: earlier or later?
Federico Paolini Paoletti et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
Astrocyte support is important for the compensatory potential of the nigrostriatal system neurons during early neurodegeneration
Katarzyna Kuter et al.
JOURNAL OF NEUROCHEMISTRY (2019)
Role of Ketogenic Diets in Neurodegenerative Diseases (Alzheimer's Disease and Parkinson's Disease)
Dariusz Wlodarek
NUTRIENTS (2019)
Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson's Disease
Angelique di Domenico et al.
STEM CELL REPORTS (2019)
Systems biology identifies preserved integrity but impaired metabolism of mitochondria due to a glycolytic defect in Alzheimer's disease neurons
Pierre Theurey et al.
AGING CELL (2019)
Mathematical Biology Models of Parkinson's Disease
Suruchi Bakshi et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2019)
Impact of gene mutation in the development of Parkinson's disease
Suganya Selvaraj et al.
GENES & DISEASES (2019)
Reducing oxidative toxicity of L-dopa in combination with two different antioxidants: an essential oil isolated from Rosa Damascena Mill., and vitamin C
Galina Nikolova et al.
TOXICOLOGY REPORTS (2019)
Understanding the role of glycogen synthase kinase-3 in L-DOPA-induced dyskinesia in Parkinson's disease
Hojin Choi et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2018)
200 Years of Parkinson's disease: what have we learnt from James Parkinson?
Claire McDonald et al.
AGE AND AGEING (2018)
Alpha-synuclein aggregates activate calcium pump SERCA leading to calcium dysregulation
Cristine Betzer et al.
EMBO REPORTS (2018)
Determinants of dopaminergic neuron loss in Parkinson's disease
Dalton James Surmeier
FEBS JOURNAL (2018)
Effects of pH and Oxidants on the First Steps of Polydopamine Formation: A Thermodynamic Approach
Mikko Salomaki et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2018)
Mild TBI and risk of Parkinson disease A Chronic Effects of Neurotrauma Consortium Study
Raquel C. Gardner et al.
NEUROLOGY (2018)
Dopamine's Effects on Corticostriatal Synapses during Reward-Based Behaviors
Nigel S. Bamford et al.
NEURON (2018)
Mitochondria, telomeres and cell senescence: Implications for lung ageing and disease
Jodie Birch et al.
PHARMACOLOGY & THERAPEUTICS (2018)
α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson's disease
Marthe H. R. Ludtmann et al.
NATURE COMMUNICATIONS (2018)
Can Interactions Between α-Synuclein, Dopamine and Calcium Explain Selective Neurodegeneration in Parkinson's Disease?
Michael R. Post et al.
FRONTIERS IN NEUROSCIENCE (2018)
On Cell Loss and Selective Vulnerability of Neuronal Populations in Parkinson's Disease
Nicolas Giguere et al.
FRONTIERS IN NEUROLOGY (2018)
Glia-neuron energy metabolism in health and diseases: New insights into the role of nervous system metabolic transporters
Mithilesh Kumar Jha et al.
EXPERIMENTAL NEUROLOGY (2018)
Low-Fat Versus Ketogenic Diet in Parkinson's Disease: A Pilot Randomized Controlled Trial
Matthew C. L. Phillips et al.
MOVEMENT DISORDERS (2018)
Microglial Implication in Parkinson's Disease: Loss of Beneficial Physiological Roles or Gain of Inflammatory Functions?
Cynthia Lecours et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
Dopamine Autoxidation Is Controlled by Acidic pH
Nejc Umek et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Guidelines on experimental methods to assess mitochondrial dysfunction in cellular models of neurodegenerative diseases
Niamh M. C. Connolly et al.
CELL DEATH AND DIFFERENTIATION (2018)
Differential pH Dynamics in Synaptic Vesicles From Intact Glutamatergic and GABAergic Synapses
Melissa A. Herman et al.
FRONTIERS IN SYNAPTIC NEUROSCIENCE (2018)
Twenty years of ModelDB and beyond: building essential modeling tools for the future of neuroscience
Robert A. McDougal et al.
JOURNAL OF COMPUTATIONAL NEUROSCIENCE (2017)
Combining Genotype, Phenotype, and Environment to Infer Potential Candidate Genes
Benoit Talbot et al.
JOURNAL OF HEREDITY (2017)
Arterial Stiffness and Cardiovascular Autonomic Dysfunction in Patients with Parkinson's Disease
Joong-Seok Kim et al.
NEURODEGENERATIVE DISEASES (2017)
Intracellular Ca2+ Sensing: Its Role in Calcium Homeostasis and Signaling
Rafaela Bagur et al.
MOLECULAR CELL (2017)
Selective neuronal vulnerability in Parkinson disease
D. James Surmeier et al.
NATURE REVIEWS NEUROSCIENCE (2017)
The Role of Astrocyte Dysfunction in Parkinson's Disease Pathogenesis
Heather D. E. Booth et al.
TRENDS IN NEUROSCIENCES (2017)
Phenotype of postural instability/gait difficulty in Parkinson disease: relevance to cognitive impairment and mechanism relating pathological proteins and neurotransmitters
Li-Jun Zuo et al.
SCIENTIFIC REPORTS (2017)
26th Annual Computational Neuroscience Meeting (CNS*2017) of the Organization for Computational Neuroscience Antwerp, Belgium, July 15-20, 2017
[Anonymous]
BMC NEUROSCIENCE (2017)
The Impact of Mathematical Modeling in Understanding the Mechanisms Underlying Neurodegeneration: Evolving Dimensions and Future Directions
A. Lloret-Villas et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2017)
The Chemistry of Neurodegeneration: Kinetic Data and Their Implications
Matic Pavlin et al.
MOLECULAR NEUROBIOLOGY (2016)
Activation of apoptosis signalling pathways by reactive oxygen species
Maureen Redza-Dutordoir et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease
Johanna Duda et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Differential Somatic Ca2+ Channel Profile in Midbrain Dopaminergic Neurons
Fabian Philippart et al.
JOURNAL OF NEUROSCIENCE (2016)
Environmental Exposures and Parkinson's Disease
Sirisha Nandipati et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2016)
Telomere shortening leads to an acceleration of synucleinopathy and impaired microglia response in a genetic mouse model
Annika Scheffold et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)
Brain-derived neurotrophic factor and its clinical implications
Siresha Bathina et al.
ARCHIVES OF MEDICAL SCIENCE (2015)
The genetics of Parkinson's disease
Stephen Mullin et al.
BRITISH MEDICAL BULLETIN (2015)
Elevated Mitochondrial Bioenergetics and Axonal Arborization Size Are Key Contributors to the Vulnerability of Dopamine Neurons
Consiglia Pacelli et al.
CURRENT BIOLOGY (2015)
Molecular heterogeneity of midbrain dopaminergic neurons - Moving toward single cell resolution
Angela Anderegg et al.
FEBS LETTERS (2015)
Integrated dopaminergic neuronal model with reduced intracellular processes and inhibitory autoreceptors
Maell Cullen et al.
IET SYSTEMS BIOLOGY (2015)
Midcervical neuronal discharge patterns during and following hypoxia
M. S. Sandhu et al.
JOURNAL OF NEUROPHYSIOLOGY (2015)
From Intrinsic Firing Properties to Selective Neuronal Vulnerability in Neurodegenerative Diseases
Francesco Roselli et al.
NEURON (2015)
DOPAMINE MIDBRAIN NEURONS IN HEALTH AND PARKINSON'S DISEASE: EMERGING ROLES OF VOLTAGE-GATED CALCIUM CHANNELS AND ATP-SENSITIVE POTASSIUM CHANNELS
E. Dragicevic et al.
NEUROSCIENCE (2015)
Adaptations of Presynaptic Dopamine Terminals Induced by Psychostimulant Self-Administration
Cody A. Siciliano et al.
ACS CHEMICAL NEUROSCIENCE (2015)
The metabolic response to excitotoxicity - lessons from single-cell imaging
Niamh M. C. Connolly et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2015)
Enteric Glial Cells: New Players in Parkinson's Disease?
Thomas Clairembault et al.
MOVEMENT DISORDERS (2015)
Dr. Otto Heinrich Warburg-Survivor of Ethical Storms
George M. Weisz
RAMBAM MAIMONIDES MEDICAL JOURNAL (2015)
Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease
Christopher L. German et al.
PHARMACOLOGICAL REVIEWS (2015)
Environmental Toxins and Parkinson's Disease
Samuel M. Goldman
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54 (2014)
Premotor and nonmotor features of Parkinson's disease
Jennifer G. Goldman et al.
CURRENT OPINION IN NEUROLOGY (2014)
A further update on the role of excitotoxicity in the pathogenesis of Parkinson's disease
Giulia Ambrosi et al.
JOURNAL OF NEURAL TRANSMISSION (2014)
Single-Cell Imaging of Bioenergetic Responses to Neuronal Excitotoxicity and Oxygen and Glucose Deprivation
Niamh M. C. Connolly et al.
JOURNAL OF NEUROSCIENCE (2014)
HETEROGENEITY OF DOPAMINE NEURON ACTIVITY ACROSS TRAITS AND STATES
M. Marinelli et al.
NEUROSCIENCE (2014)
THE ROLE OF D2-AUTORECEPTORS IN REGULATING DOPAMINE NEURON ACTIVITY AND TRANSMISSION
C. P. Ford
NEUROSCIENCE (2014)
Empirical valence bond simulations of the hydride transfer step in the monoamine oxidase B catalyzed metabolism of dopamine
Matej Repic et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2014)
Molecular determinants of selective dopaminergic vulnerability in Parkinson's disease: an update
Lars Brichta et al.
FRONTIERS IN NEUROANATOMY (2014)
NON-LINEAR DEVELOPMENTAL TRAJECTORY OF ELECTRICAL PHENOTYPE IN RAT SUBSTANTIA NIGRA PARS COMPACTA DOPAMINERGIC NEURONS
Martial A. Dufour et al.
ELIFE (2014)
Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis
Matthew Brentnall et al.
BMC CELL BIOLOGY (2013)
A single compartment model of pacemaking in dissasociated substantia nigra neurons Stability and energy analysis
Febe Francis et al.
JOURNAL OF COMPUTATIONAL NEUROSCIENCE (2013)
The Genetics of Parkinson's Disease: Progress and Therapeutic Implications
Andrew B. Singleton et al.
MOVEMENT DISORDERS (2013)
Genotype and Phenotype in Parkinson's Disease: Lessons in Heterogeneity From Deep Brain Stimulation
Aikaterina Angeli et al.
MOVEMENT DISORDERS (2013)
What can neurons do for their brain? Communicate selectivity with bursts
David Balduzzi et al.
THEORY IN BIOSCIENCES (2013)
Sugar for the brain: the role of glucose in physiological and pathological brain function
Philipp Mergenthaler et al.
TRENDS IN NEUROSCIENCES (2013)
The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson's disease
Eleftheria K. Pissadaki et al.
FRONTIERS IN COMPUTATIONAL NEUROSCIENCE (2013)
Cellular Mechanisms Controlling Caspase Activation and Function
Amanda B. Parrish et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
NMDA receptor-mediated excitotoxicity depends on the coactivation of synaptic and extrasynaptic receptors
X. Zhou et al.
CELL DEATH & DISEASE (2013)
Information and Efficiency in the Nervous System-A Synthesis
Biswa Sengupta et al.
PLOS COMPUTATIONAL BIOLOGY (2013)
Cellular and molecular mechanisms of mitochondrial function
Laura D. Osellame et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Computational modeling of apoptotic signaling pathways induced by cisplatin
Ji-Young Hong et al.
BMC SYSTEMS BIOLOGY (2012)
Dynamic modelling of protein and oxidative metabolisms simulates the pathogenesis of Parkinson's disease
M. Cloutier et al.
IET SYSTEMS BIOLOGY (2012)
Cutting Edge: IL-13Rα1 Expression in Dopaminergic Neurons Contributes to Their Oxidative Stress-Mediated Loss following Chronic Peripheral Treatment with Lipopolysaccharide
Brad E. Morrison et al.
JOURNAL OF IMMUNOLOGY (2012)
Dual Control of Dopamine Synthesis and Release by Presynaptic and Postsynaptic Dopamine D2 Receptors
Andrea Anzalone et al.
JOURNAL OF NEUROSCIENCE (2012)
Living on the edge with too many mouths to feed: Why dopamine neurons die
J. Paul Bolam et al.
MOVEMENT DISORDERS (2012)
Astrocyte-derived GDNF is a potent inhibitor of microglial activation
Sandra Moreira Rocha et al.
NEUROBIOLOGY OF DISEASE (2012)
Mathematical insights into the effects of levodopa
Michael C. Reed et al.
FRONTIERS IN INTEGRATIVE NEUROSCIENCE (2012)
A critical review of evidence for preclinical differences between rasagiline and selegiline
Manfred Gerlach et al.
BASAL GANGLIA (2012)
Estimation of Intracellular Fluxes in Cerebellar Neurons After Hypoglycemia: Importance of the Pyruvate Recycling Pathway and Glutamine Oxidation
Ana I. Amaral et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2011)
A reduced model of DA neuronal dynamics that displays quiescence, tonic firing and bursting
A. M. Oster et al.
JOURNAL OF PHYSIOLOGY-PARIS (2011)
Levodopa toxicity and Parkinson disease Still a need for equipoise
C. Warren Olanow et al.
NEUROLOGY (2011)
Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson's Disease
Wei Zhang et al.
NEUROTOXICITY RESEARCH (2011)
L-DOPA: A scapegoat for accelerated neurodegeneration in Parkinson's disease?
Janusz Lipski et al.
PROGRESS IN NEUROBIOLOGY (2011)
An energy systems approach to Parkinson's disease
Peter Wellstead et al.
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2011)
Mitochondrial Energetics and Therapeutics
Douglas C. Wallace et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2010)
Calpain and caspase processing of caspase-12 contribute to the ER stress-induced cell death pathway in differentiated PC12 cells
Juan A. Martinez et al.
APOPTOSIS (2010)
Salicylic acid protects against chronic L-DOPA-induced 6-OHDA generation in experimental model of parkinsonism
Anupom Borah et al.
BRAIN RESEARCH (2010)
Mechanisms Underlying Inflammation in Neurodegeneration
Christopher K. Glass et al.
CELL (2010)
The control systems structures of energy metabolism
Mathieu Cloutier et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2010)
α-Synuclein and dopamine at the crossroads of Parkinson's disease
Lara Lourenco Venda et al.
TRENDS IN NEUROSCIENCES (2010)
Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps
Oren A. Levy et al.
APOPTOSIS (2009)
Cellular responses to endoplasmic reticulum stress and apoptosis
Vanya I. Rasheva et al.
APOPTOSIS (2009)
Amphetamine-evoked rotation requires newly synthesized dopamine at 14 days but not 1 day after intranigral 6-OHDA and is consistently dissociated from sensorimotor behavior
Melanie A. Paquette et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Regulation of astrocyte inflammatory responses by the Parkinson's disease-associated gene DJ-1
Jens Waak et al.
FASEB JOURNAL (2009)
A kinetic model unifying presynaptic short-term facilitation and depression
Chuang-Chung J. Lee et al.
JOURNAL OF COMPUTATIONAL NEUROSCIENCE (2009)
An integrative dynamic model of brain energy metabolism using in vivo neurochemical measurements
Mathieu Cloutier et al.
JOURNAL OF COMPUTATIONAL NEUROSCIENCE (2009)
Endogenous Calcium Buffering Capacity of Substantia Nigral Dopamine Neurons
R. C. Foehring et al.
JOURNAL OF NEUROPHYSIOLOGY (2009)
Robust Pacemaking in Substantia Nigra Dopaminergic Neurons
Jaime N. Guzman et al.
JOURNAL OF NEUROSCIENCE (2009)
Interplay between Cytosolic Dopamine, Calcium, and α-Synuclein Causes Selective Death of Substantia Nigra Neurons
Eugene V. Mosharov et al.
NEURON (2009)
Homeostatic mechanisms in dopamine synthesis and release: a mathematical model
Janet A. Best et al.
THEORETICAL BIOLOGY AND MEDICAL MODELLING (2009)
Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease
Luigi Zecca et al.
ACTA NEUROPATHOLOGICA (2008)
Calcium ions in neuronal degeneration
Urszula Wojda et al.
IUBMB LIFE (2008)
The clinical relevance of levodopa toxicity in the treatment of Parkinson's disease
Anthony H. V. Schapira
MOVEMENT DISORDERS (2008)
Glial reactions in Parkinson's disease
Patrick L. McGeer et al.
MOVEMENT DISORDERS (2008)
Glial Cells as Players in Parkinsonism: The Good, the Bad, and the Mysterious Glia
Maria A. Mena et al.
NEUROSCIENTIST (2008)
Inflammation as a causative factor in the aetiology of Parkinson's disease
P. S. Whitton
BRITISH JOURNAL OF PHARMACOLOGY (2007)
'Rejuvenation' protects neurons in mouse models of Parkinson's disease
C. Savio Chan et al.
NATURE (2007)
Blood-brain barrier disruption induces in vivo degeneration of nigral dopaminergic neurons
Inmaculada Rite et al.
JOURNAL OF NEUROCHEMISTRY (2007)
The action potential in mammalian central neurons
Bruce P. Bean
NATURE REVIEWS NEUROSCIENCE (2007)
Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease
David Sulzer
TRENDS IN NEUROSCIENCES (2007)
Regulation of firing of dopaminergic neurons and control of goal-directed behaviors
Anthony A. Grace et al.
TRENDS IN NEUROSCIENCES (2007)
Mitochondria mass is low in mouse substantia nigra dopamine neurons: Implications for Parkinson's disease
Chang-Lin Liang et al.
EXPERIMENTAL NEUROLOGY (2007)
Physiology and pathophysiology of purinergic neurotransmission
Geoffrey Burnstock
PHYSIOLOGICAL REVIEWS (2007)
Calcium microdomains in regulated exocytosis
Martin Oheim et al.
CELL CALCIUM (2006)
Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons
Y Kraytsberg et al.
NATURE GENETICS (2006)
Ageing and neuronal vulnerability
MP Mattson et al.
NATURE REVIEWS NEUROSCIENCE (2006)
Does levodopa slow or hasten the rate of progression of Parkinson's disease?
S Fahn
JOURNAL OF NEUROLOGY (2005)
Signaling pathways in the nitric oxide and iron-induced dopamine release in the striatum of freely moving rats:: Role of extracellular Ca2+ and L-type Ca2+ channels
G Rocchitta et al.
BRAIN RESEARCH (2005)
Cerebral ketone body metabolism
AAM Morris
JOURNAL OF INHERITED METABOLIC DISEASE (2005)
Rationale for and use of NMDA receptor antagonists in Parkinson's disease
PJ Hallett et al.
PHARMACOLOGY & THERAPEUTICS (2004)
Long term motor complications of levodopa: clinical features, mechanisms, and management strategies
BR Thanvi et al.
POSTGRADUATE MEDICAL JOURNAL (2004)
Cytochrome C-mediated apoptosis
XJ Jiang et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2004)
Calcium, ATP, and ROS: a mitochondrial love-hate triangle
PS Brookes et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2004)
Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: Human midbrain dopamine neurons
CL Liang et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2004)
Analysis of glutathione: implication in redox and detoxification
A Pastore et al.
CLINICA CHIMICA ACTA (2003)
Dopamine- or L-DOPA-induced neurotoxicity: The role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease
M Asanuma et al.
NEUROTOXICITY RESEARCH (2003)
Simple model of spiking neurons
EM Izhikevich
IEEE TRANSACTIONS ON NEURAL NETWORKS (2003)
An endoplasmic reticulum stress-specific caspase cascade in apoptosis -: Cytochrome c-independent activation of caspase-9 by caspase-12
N Morishima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
An energy budget for signaling in the grey matter of the brain
D Attwell et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2001)
Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B
MBH Youdim et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Complex calcium oscillations and the role of mitochondria and cytosolic proteins
M Marhl et al.
BIOSYSTEMS (2000)
Glutamate as a neurotransmitter in the brain: Review of physiology and pathology
BS Meldrum
JOURNAL OF NUTRITION (2000)
The pedunculopontine nucleus and Parkinson's disease
PA Pahapill et al.
BRAIN (2000)
Share Paper
